Literature DB >> 24688607

Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Sung-Jae Park1, Young S Hahn2.   

Abstract

Hepatitis C virus (HCV) infection in humans is remarkably efficient in establishing viral persistence, leading to the development of liver cirrhosis and hepatocellular carcinoma. CD8+ T cells are involved in controlling HCV infection; but, in chronic HCV patients, severe CD4+ and CD8+ T cell dysfunction has been observed. This suggests that HCV may employ numerous mechanisms to counteract or possibly suppress the host T cell responses. The primary site of HCV replication occurs within hepatocytes in the liver. As a result of liver enodothelial cells perforated by fenestrations, parenchymal cells (hepatocytes) are not separated by a basal membrane, and thereby HCV-infected hepatocytes are extensively capable of interacting with innate immune cells including NK, DC. Recent studies reveal that the function of NK and DC function is significantly impaired in chronic HCV patients. Given a critical role of NK and DC in limiting HCV replication at the early phase of viral infection, it is likely that HCV-infected hepatocytes might be responsible for impairing NK and DC function by enhancing the expression of immunoregulatory molecules (either soluble or cell surface). Thus, this impairment of innate immunity attributes to the failure of generating effective T cell responses to clear HCV infection. In this article, we will review studies highlighting the regulation of innate immunity by HCV and crosstalk between hepatocytes and NK/DC in the hepatic environment.

Entities:  

Keywords:  DC; TLR activation; evasion of TLR signaling; innate immunity; the impaired function of NK

Year:  2010        PMID: 24688607      PMCID: PMC3969740     

Source DB:  PubMed          Journal:  Rev Infect


  70 in total

Review 1.  Altered innate immunity in chronic hepatitis C infection: cause or effect?

Authors:  Gyongyi Szabo; Serena Chang; Angela Dolganiuc
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 2.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.

Authors:  Eui-Cheol Shin; Ulrike Seifert; Takanobu Kato; Charles M Rice; Stephen M Feinstone; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

5.  The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valeska Hofmeister; Golo Ahlenstiel; Henning Zimmermann; Ludger Leifeld; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons.

Authors:  Jonathan Larkin; Anne Bost; John I Glass; Seng-Lai Tan
Journal:  J Interferon Cytokine Res       Date:  2006-12       Impact factor: 2.607

Review 7.  Modulation of dendritic cell function by persistent viruses.

Authors:  Bisheng Liu; Andrea M Woltman; Harry L A Janssen; Andre Boonstra
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

8.  Mechanism of the interferon alpha response against hepatitis C virus replicons.

Authors:  Ju-Tao Guo; Ji A Sohn; Qing Zhu; Christoph Seeger
Journal:  Virology       Date:  2004-07-20       Impact factor: 3.616

9.  Natural killer cells suppress full cycle HCV infection of human hepatocytes.

Authors:  S-H Wang; C-X Huang; L Ye; X Wang; L Song; Y-J Wang; H Liang; X-Y Huang; W-Z Ho
Journal:  J Viral Hepat       Date:  2008-07-10       Impact factor: 3.728

10.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  3 in total

Review 1.  Hepatitis C, innate immunity and alcohol: friends or foes?

Authors:  Natalia A Osna; Murali Ganesan; Kusum K Kharbanda
Journal:  Biomolecules       Date:  2015-02-05

Review 2.  Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure.

Authors:  Stephen J Polyak; I Nicholas Crispe; Thomas F Baumert
Journal:  Pathogens       Date:  2021-01-07

3.  Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.

Authors:  Cameron R Cunningham; Ameya Champhekar; Michael V Tullius; Barbara Jane Dillon; Anjie Zhen; Justin Rafael de la Fuente; Jonathan Herskovitz; Heidi Elsaesser; Laura M Snell; Elizabeth B Wilson; Juan Carlos de la Torre; Scott G Kitchen; Marcus A Horwitz; Steven J Bensinger; Stephen T Smale; David G Brooks
Journal:  PLoS Pathog       Date:  2016-01-25       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.